{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T08:33:51Z","timestamp":1794818031538,"version":"4.9.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    As children progress to higher stages of AKI, the risk for adverse outcomes dramatically increases. No reliable methods exist to predict AKI progression in hospitalized children. To determine if biomarkers of inflammation and kidney injury can predict AKI progression, we conducted a three-center prospective cohort study of children undergoing cardiopulmonary bypass.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    On the first day of serum creatinine\u2013defined AKI, we measured urine biomarkers (neutrophil gelatinase\u2013associated lipocalin [NGAL], IL-18, kidney injury molecule 1, liver fatty acid binding protein [L-FABP], albumin, and cystatin C) and plasma biomarkers (IFN, IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, TNF-\n                    <jats:italic toggle=\"yes\">\u03b1<\/jats:italic>\n                    , NGAL, and cystatin C). We defined AKI progression as a worsening of AKI stage or persisting stage 3 AKI (\u22652 consecutive days).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    In all, 176 of 408 (43%) children developed postoperative AKI. Among the children with AKI, we diagnosed stages 1, 2, and 3 AKI in 145 (82.5%), 25 (14%), and six (3.5%) children, respectively, on the first day of AKI; 28 (7%) children had AKI progression. On the first day of AKI, nine of 17 biomarkers were significantly higher in patients with than without AKI progression. Urine L-FABP (among injury biomarkers) and plasma IL-8 (among inflammatory biomarkers) had the highest discrimination for AKI progression: optimism-corrected area under the curve, 0.70; 95% confidence interval, 0.58 to 0.81 and optimism-corrected area under the curve, 0.80; 95% confidence interval, 0.69 to 0.91, respectively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    If validated in additional cohorts, plasma IL-8 could be used to improve clinical care and guide enrollment in therapeutic trials of AKI.\n                  <\/jats:p>","DOI":"10.1681\/asn.2017090989","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T10:58:22Z","timestamp":1519297102000},"page":"1549-1556","source":"Crossref","is-referenced-by-count":69,"title":["Biomarkers of AKI Progression after Pediatric Cardiac Surgery"],"prefix":"10.1681","volume":"29","author":[{"given":"Jason H.","family":"Greenberg","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and"},{"name":"Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zappitelli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Nephrology, McGill University Health Centre, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0842-468X","authenticated-orcid":false,"given":"Yaqi","family":"Jia","sequence":"additional","affiliation":[{"name":"Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-0514","authenticated-orcid":false,"given":"Heather R.","family":"Thiessen-Philbrook","sequence":"additional","affiliation":[{"name":"Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"de Fontnouvelle","sequence":"additional","affiliation":[{"name":"Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Perry","family":"Wilson","sequence":"additional","affiliation":[{"name":"Internal Medicine, Section of Nephrology and"},{"name":"Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut;"},{"name":"Department of Internal Medicine, Section of Nephrology, Veterans Affairs Medical Center, West Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-9168","authenticated-orcid":false,"given":"Steven","family":"Coca","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Nephrology, Mount Sinai School of Medicine, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Devarajan","sequence":"additional","affiliation":[{"name":"Nephrology and Hypertension, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Internal Medicine, Section of Nephrology and"},{"name":"Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut;"},{"name":"Department of Internal Medicine, Section of Nephrology, Veterans Affairs Medical Center, West Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"B1-20231016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1611391","article-title":"Epidemiology of acute kidney injury in critically ill children and young adults.","volume":"376","author":"Kaddourah","year":"2017","journal-title":"N Engl J Med"},{"key":"B2-20231016","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.00270113","article-title":"AKI in hospitalized children: Epidemiology and clinical associations in a national cohort.","volume":"8","author":"Sutherland","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3-20231016","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/CCM.0b013e31821201d3","article-title":"Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: A prospective multicenter study.","volume":"39","author":"Li","year":"2011","journal-title":"Crit Care Med"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.01900214","article-title":"AKI in hospitalized children: Comparing the pRIFLE, AKIN, and KDIGO definitions.","volume":"10","author":"Sutherland","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease.","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1681\/ASN.2014111114","article-title":"Elevated BP after AKI.","volume":"27","author":"Hsu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis.","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00467-011-2024-5","article-title":"Renal angina: An emerging paradigm to identify children at risk for acute kidney injury.","volume":"27","author":"Basu","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00467-010-1576-0","article-title":"Biomarkers of acute kidney injury in children: Discovery, evaluation, and clinical application.","volume":"26","author":"Al-Ismaili","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2011090907","article-title":"Biomarkers predict progression of acute kidney injury after cardiac surgery.","volume":"23","author":"Koyner","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1681\/ASN.2010121302","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B12-20231016","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.10971012","article-title":"Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.","volume":"8","author":"Parikh","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jamapediatrics.2015.54","article-title":"Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.","volume":"169","author":"Zappitelli","year":"2015","journal-title":"JAMA Pediatr"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00467-015-3088-4","article-title":"Interleukin-6 and interleukin-10 as acute kidney injury biomarkers in pediatric cardiac surgery.","volume":"30","author":"Greenberg","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"e93460","DOI":"10.1371\/journal.pone.0093460","article-title":"Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.","volume":"9","author":"Meersch","year":"2014","journal-title":"PLoS One"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1542\/peds.2014-2949","article-title":"Cardiac biomarkers and acute kidney injury after cardiac surgery.","volume":"135","author":"Bucholz","year":"2015","journal-title":"Pediatrics"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"B18-20231016","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.athoracsur.2017.04.038","article-title":"Interleukin-8 and tumor necrosis factor predict acute kidney injury after pediatric cardiac surgery.","volume":"104","author":"de Fontnouvelle","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1067\/mtc.2002.119064","article-title":"Consensus-based method for risk adjustment for surgery for congenital heart disease.","volume":"123","author":"Jenkins","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"B21-20231016","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00259-006-0179-2","article-title":"Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children.","volume":"33","author":"Piepsz","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B23-20231016","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2011.123","article-title":"Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery.","volume":"80","author":"Zappitelli","year":"2011","journal-title":"Kidney Int"},{"key":"B24-20231016","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00467-017-3748-7","article-title":"Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass.","volume":"32","author":"Dong","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2215\/CJN.12751211","article-title":"The association of albumin\/creatinine ratio with postoperative AKI in children undergoing cardiac surgery.","volume":"7","author":"Zappitelli","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"e0164832","DOI":"10.1371\/journal.pone.0164832","article-title":"Storage time and urine biomarker levels in the ASSESS-AKI study.","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"B27-20231016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40364-014-0027-7","article-title":"RiGoR: Reporting guidelines to address common sources of bias in risk model development.","volume":"3","author":"Kerr","year":"2015","journal-title":"Biomark Res"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ki.2015.283","article-title":"Methodological issues in current practice may lead to bias in the development of biomarker combinations for predicting acute kidney injury.","volume":"89","author":"Meisner","year":"2016","journal-title":"Kidney Int"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1).","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1681\/ASN.2014080764","article-title":"Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery.","volume":"26","author":"Zhang","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B31-20231016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.02510706","article-title":"Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.","volume":"2","author":"Chawla","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B32-20231016","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1681\/ASN.2003090757","article-title":"Maladaptive role of IL-6 in ischemic acute renal failure.","volume":"16","author":"Kielar","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B33-20231016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2369-14-17","article-title":"Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation.","volume":"14","author":"Sirota","year":"2013","journal-title":"BMC Nephrol"},{"key":"B34-20231016","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1681\/ASN.2005030236","article-title":"Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit.","volume":"16","author":"Parikh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B35-20231016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5500\/wjt.v3.i4.91","article-title":"Role of IL-10 in the progression of kidney disease.","volume":"3","author":"Sinuani","year":"2013","journal-title":"World J Transplant"},{"key":"B36-20231016","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis.","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"B37-20231016","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1681\/ASN.2007111200","article-title":"Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells.","volume":"19","author":"Kuo","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B38-20231016","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/cc7940","article-title":"Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: A case-control study.","volume":"13","author":"Liu","year":"2009","journal-title":"Crit Care"},{"key":"B39-20231016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/2193-1801-3-207","article-title":"Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsis.","volume":"3","author":"Powell","year":"2014","journal-title":"Springerplus"},{"key":"B40-20231016","first-page":"639","article-title":"Fluid balance and conventional and novel biomarkers of acute kidney injury in cardiovascular surgery.","volume":"54","author":"Kambhampati","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"B41-20231016","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3109\/0886022X.2016.1165070","article-title":"Urinary markers of acute kidney injury in newborns with perinatal asphyxia (.).","volume":"38","author":"Oncel","year":"2016","journal-title":"Ren Fail"},{"key":"B42-20231016","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2215\/CJN.09911014","article-title":"Biomarker enhanced risk prediction for adverse outcomes in critically ill patients receiving RRT.","volume":"10","author":"Pike","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B43-20231016","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1523-1755.2004.00512.x","article-title":"Plasma cytokine levels predict mortality in patients with acute renal failure.","volume":"65","author":"Simmons","year":"2004","journal-title":"Kidney Int"},{"key":"B44-20231016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: Current understanding, key questions, and knowledge gaps.","volume":"27","author":"Rabb","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B45-20231016","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.2012060633","article-title":"Messengers without borders: Mediators of systemic inflammatory response in AKI.","volume":"24","author":"Ratliff","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B46-20231016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-6576.2001.045004407.x","article-title":"Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs.","volume":"45","author":"Brix-Christensen","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"B47-20231016","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1034\/j.1399-6576.2001.045006671.x","article-title":"The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children.","volume":"45","author":"Brix-Christensen","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"B48-20231016","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0022-5223(19)33968-6","article-title":"Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.","volume":"106","author":"Seghaye","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B49-20231016","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.2010111163","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery.","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B50-20231016","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1093\/ndt\/gfr110","article-title":"Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.","volume":"26","author":"Kanaguchi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B51-20231016","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/cc6089","article-title":"Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study.","volume":"11","author":"Zappitelli","year":"2007","journal-title":"Crit Care"},{"key":"B52-20231016","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00467-006-0146-y","article-title":"Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: A novel marker of renal injury.","volume":"21","author":"Trachtman","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"B53-20231016","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000363254","article-title":"Repair or progression after AKI: A role for biomarkers?","volume":"127","author":"Srisawat","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"B55-20231016","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.12851216","article-title":"Biomarkers for diagnosis and prognosis of AKI in children: One size does not fit all.","volume":"12","author":"Greenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B56-20231016","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1740774517723588","article-title":"Evaluating biomarkers for prognostic enrichment of clinical trials.","volume":"14","author":"Kerr","year":"2017","journal-title":"Clin Trials"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201805000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:30:54Z","timestamp":1786131054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201805000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2017090989","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]}}}